Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

McQuade

Showing results (721-730 of 1,025) with videos related to

Pageof 103
Sort By:
Journal of Medical Economics|October 28, 2014
Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysisJohn M Kane, Cathy Zhao, Brian R Johnson, et al.
Biochemical Pharmacology|May 15, 1985
A monoclonal antibody raised to rat liver cytochrome P-448 (form C) which recognises an epitope common to many other forms of cytochrome P-450A R Boobis, J McQuade, D Sesardic, et al.
Behavioral Medicine (Washington, D.C.)|January 20, 2000
Sense of control and adjustment to breast cancer: the importance of balancing control coping stylesJ A Astin, H Anton-Culver, C E Schwartz, et al.
Biochemical Pharmacology|December 15, 1986
Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450 cJ R Foster, C R Elcombe, A R Boobis, et al.
Neuroscience Letters|May 12, 2006
Deficient hippocampal c-fos expression results in reduced anxiety and altered response to chronic stress in female miceJill M Slane McQuade, Kellie L K Tamashiro, Gwendolyn E Wood, et al.
Journal of Medical Economics|May 14, 2013
Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophreniaJohn M Kane, Raymond Sanchez, Joan Zhao, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studiesPhilip G Janicak, Ira D Glick, Stephen R Marder, et al.
The Journal of Clinical Psychiatry|August 25, 2015
Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind studyMichael E Thase, James M Youakim, Aleksandar Skuban, et al.
Schizophrenia Research|February 18, 2006
A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA)Rajiv Tandon, Ronald N Marcus, Elyse G Stock, et al.
Theranostics|August 22, 2017
Al<sup>18</sup>F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography ImagingFrederik Cleeren, Joan Lecina, Muneer Ahamed, et al.
Pageof 103

Showing results (721-730 of 1,025) with videos related to

Sort By:
Pageof 103
Journal of Medical Economics|October 28, 2014
Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysisJohn M Kane, Cathy Zhao, Brian R Johnson, et al.
Biochemical Pharmacology|May 15, 1985
A monoclonal antibody raised to rat liver cytochrome P-448 (form C) which recognises an epitope common to many other forms of cytochrome P-450A R Boobis, J McQuade, D Sesardic, et al.
Behavioral Medicine (Washington, D.C.)|January 20, 2000
Sense of control and adjustment to breast cancer: the importance of balancing control coping stylesJ A Astin, H Anton-Culver, C E Schwartz, et al.
Biochemical Pharmacology|December 15, 1986
Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450 cJ R Foster, C R Elcombe, A R Boobis, et al.
Neuroscience Letters|May 12, 2006
Deficient hippocampal c-fos expression results in reduced anxiety and altered response to chronic stress in female miceJill M Slane McQuade, Kellie L K Tamashiro, Gwendolyn E Wood, et al.
Journal of Medical Economics|May 14, 2013
Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophreniaJohn M Kane, Raymond Sanchez, Joan Zhao, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studiesPhilip G Janicak, Ira D Glick, Stephen R Marder, et al.
The Journal of Clinical Psychiatry|August 25, 2015
Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind studyMichael E Thase, James M Youakim, Aleksandar Skuban, et al.
Schizophrenia Research|February 18, 2006
A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA)Rajiv Tandon, Ronald N Marcus, Elyse G Stock, et al.
Theranostics|August 22, 2017
Al<sup>18</sup>F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography ImagingFrederik Cleeren, Joan Lecina, Muneer Ahamed, et al.
Pageof 103